Odee: Gregory Harris
OfbọChị Okike: 14 Onwa Epurel 2021
DatebọChị Mmelite: 24 Juunu 2024
Anonim
Mode of action of Saccharomyces boulardii CNCM I-745
Vidio: Mode of action of Saccharomyces boulardii CNCM I-745

Ndinaya

Saccharomyces boulardii bụ yist. Achọpụtara ya na mbụ dị ka ụdị yist pụrụ iche. Ugbu a ekwenyere na ọ bụ nje Saccharomyces cerevisiae. Ma Saccharomyces boulardii di iche na nsogbu ndi ozo nke Saccharomyces cerevisiae nke a na-akpo dika yist nke brewer na nke achicha bred. A na-eji Saccharomyces boulardii eme ihe dị ka ọgwụ.

A na-ejikarị Saccharomyces boulardii eme ihe maka ịgwọ na igbochi afọ ọsịsa, gụnyere ụdị ndị na-efe efe dị ka afọ ọsịsa rotaviral na ụmụaka. O nwere ụfọdụ ihe akaebe nke iji maka ụdị afọ ọsịsa ndị ọzọ, ihe otutu, na ọrịa na-agbari nri nke nwere ike ibute ọnya.

Ọrịa Coronavirus 2019 (COVID-19): Enweghị ezigbo ihe akaebe iji kwado iji Saccharomyces boulardii maka COVID-19. Soro nhọrọ ndụ dị mma na usoro mgbochi egosipụtara kama.

Natural Medicines Comprehensive database ọnụego na-arụ ọrụ dabere na ihe akaebe sayensị dịka usoro a si dị: Mmetụta, Ikekwe Ọ Ga-arụpụta Ihe, Ikekwe Ọ Ga-arụpụta Ihe, Ikekwe Ọ Dị Irè, Ikekwe Ọ Dị Irè, Adịghị Eme Ihe, na Ego ezughi ezu iji gosi.

Radị irè maka SACCHAROMYCES BOULARDII ndị dị ka ndị a:


Ikekwe ọ dị irè maka ...

  • Afọ ọsịsa. Nnyocha na-egosi na inye ụmụaka afọ ọsịsa Saccharomyces boulardii nwere ike belata oge ọ ga-ewe ruo ụbọchị 1. Mana ọ dị ka Saccharomyces boulardii adịghị arụ ọrụ karịa ọgwụ ndị na-emebu maka afọ ọsịsa, dịka loperamide (Imodium).
  • Afọ ọsịsa nke rotavirus kpatara. Inye ụmụaka Saccharomyces boulardii na ụmụaka nwere afọ ọsịsa nke rotavirus kpatara nwere ike belata oge afọ ọsịsa ga-adịru ihe dịka ụbọchị 1.

Ekwe omume irè n'ihi na ...

  • Ihe otutu. Nnyocha na-egosi na ị thatụ Saccharomyces boulardii n'ọnụ na-enyere aka melite ọdịdị nke ihe otutu.
  • Afọ na ndị mmadụ na-a antibioticsụ ọgwụ nje.. Ọtụtụ nnyocha na-egosi na Saccharomyces boulardii nwere ike inye aka igbochi afọ ọsịsa nke ndị okenye na ụmụaka na-agwọ ọgwụ nje. Maka ndị ọrịa ọ bụla 9-13 na-agwọ Saccharomyces boulardii n'oge ọgwụgwọ na ọgwụ nje, otu onye na-erughị ala ga-azụlite afọ ọsịsa metụtara ọrịa.
  • Ọrịa nke akụkụ eriri afọ site na nje bacteria a na-akpọ Clostridium siri ike. Sacnweta Saccharomyces boulardii tinyere ọgwụ nje yiri ka ọ ga-enyere aka igbochi afọ ọsịsa metụtara Clostridium na-agagharị na ndị nwere akụkọ ntolite. Sacnweta Saccharomyces boulardii tinyere ọgwụ nje na-enyekwa aka na-egbochi mbido mbụ nke afọ ọsịsa metụtara Clostridium. Mana ndị ọkachamara anaghị akwado iji Saccharomyces mee ihe iji gbochie oge mbụ.
  • Ọrịa ọrịa digestive nke nwere ike ibute ọnya (Helicobacter pylori ma ọ bụ H. pylori). Sacnara Saccharomyces boulardii site n'ọnụ ya yana ọgwụgwọ H. pylori ọkọlọtọ na-enyere aka ịgwọ ọrịa a. Ihe dị ka mmadụ iri na abụọ kwesiri ka ejiri ọgwụgwọ Saccharomyces ọzọ boulardii mesoo otu onye ọrịa nke ga-anọgide na-ebute ọrịa ka a gwọọ ya. Inweta Saccharomyces boulardii na-enye aka igbochi mmetụta ndị dị ka afọ ọsịsa na ọgbụgbọ nke na-eme na ọgwụgwọ H. pylori. Nke a nwere ike inyere ndị mmadụ aka ịmechaa usoro ọgwụgwọ ha maka H. pylori.
  • Ọrịa afọ ọsịsa nke ndị nwere nje HIV / AIDS. Iwere inyocha boulardii nke Saccharomyces na-ebelata mbelata nke metụtara nje HIV.
  • Ọrịa na-efe efe nke ukwuu na ụmụ akaghi aka (necrotizing enterocolitis ma ọ bụ NEC). Ọtụtụ nyocha na-egosi na ịnye Saccharomyces boulardii ka ụmụ ọhụrụ na-amụ nwa na-egbochi NEC.
  • Afọ ọwụwa ndị njem. Inweta Saccharomyces boulardii site na ọnụ pụtara iji gbochie afọ ọsịsa ndị njem.

Ikekwe adighi ike maka ...

  • Ọrịa ọbara (sepsis). Nnyocha e mere na-egosi na inye Saccharomyces boulardii inye ụmụ ọhụrụ amụrụ nwa anaghị egbochi sepsis.

Ezughi oke akaebe iji gosipụta irè maka ...

  • Ọrịa nke eriri afọ nke na-akpata afọ ọsịsa (ọgbụgbọ na ọnyụnyụ). Saccharomyces boulardii adịghị ka ọ dị mma mgbaàmà ọgbụgba, ọbụlagodi mgbe enyere ya ọgwụgwọ.
  • Ikike icheta echiche na iche echiche (ọrụ ime uche). Nnyocha emere na mbụ gosiri na ịnara ụmụ akwụkwọ Saccharomyces boulardii anaghị enyere ụmụ akwụkwọ aka ime nke ọma na ule ma ọ bụ belata nchekasị ha.
  • Typedị ọrịa obi na-efe efe (ọrịa Crohn). Inweta Saccharomyces boulardii yiri ka o belatara onu ogugu ndi mmadu nwere oria Crohn. Nnyocha emere na mbụ gosikwara na ịmụrụ Saccharomyces boulardii yana mesalamine nwere ike inyere ndị nwere ọrịa Crohn aka ịnọ na mgbaghara ogologo oge. Mana ịnara Saccharomyces boulardii naanị adịghị ka ọ ga - enyere ndị nwere ọrịa Crohn aka ịnọ na mgbaghara ogologo oge.
  • Ọrịa Cystic. Nnyocha mbụ emere na-egosi na ị takingụ Saccharomyces boulardii site na ọnụ anaghị ebelata ọrịa yist na akụkụ nri nke ndị nwere ọrịa cystic fibrosis.
  • Obi mgbawa. Nnyocha e mere na mbụ gosiri na ịmụrụ Saccharomyces boulardii nwere ike imeziwanye ọrụ obi na ndị nwere nkụda obi.
  • Cholesterol dị elu. Nnyocha e mere na mbụ gosiri na Saccharomyces boulardii adịghị ka ọ na-emetụta ọkwa cholesterol.
  • Ọrịa na-adịte aka nke nnukwu eriri afọ na-akpata mgbu afọ (ọrịa bowel na-adịghị mma ma ọ bụ IBS). Nnyocha na-egosi na ịmụrụ Saccharomyces boulardii na-eme ka ndụ dị mma na ndị nwere afọ ọsịsa-nke kachasị ma ọ bụ ụdị IBS. Mana Saccharomyces boulardii adịghị ka ọ na - eme ka ọtụtụ mgbaàmà IBS dị ka ihe mgbu afọ, ngwa ngwa, ma ọ bụ bloating.
  • Ofufe nke eriri afọ site na nje. Nnyocha emere na mbụ gosiri na ị takingụ Saccharomyces boulardii n'ọnụ yana ọgwụ nje na-ebelata afọ ọsịsa na mgbu afọ nke ndị nwere ọrịa amoeba.
  • Yellowing nke anụahụ na ụmụ ọhụrụ (neonatal jaundice). Fọdụ ụmụ aka na-etopụta jaundice mgbe amụrụ ha n'ihi ogo bilirubin dị elu. Inye Saccharomyces boulardii ka akpọrọ ụmụ aka nwere ike igbochi jaundice ma belata mkpa phototherapy na obere ọnụ ọgụgụ ụmụ ọhụrụ a. Mana amabeghị ma ọ bụrụ na Saccharomyces boulardii na-ebelata ihe egwu nke jaundice na ụmụ aka n'ihe egwu. Inye ụmụaka Saccharomyces boulardii yana phototherapy adịghị wedata ogo bilirubin karịa naanị phototherapy.
  • Bornmụaka a mụrụ na-erughị gram 2500 (kilogram ise, ounce asatọ). Inye ihe mgbakwunye Saccharomyces boulardii mgbe amụrụ nwa yiri ka ọ na - eme ka uru dị ukwuu na nri ụmụaka na - amụbeghị amụ.
  • Growthba ụba nke nje na obere eriri afọ. Nnyocha e mere na mbụ gosiri na ịgbakwunye Saccharomyces boulardii na ọgwụgwọ na ọgwụ nje na-ebelata nje bacteria na eriri afọ karịa ọgwụ nje naanị.
  • Typedị ọrịa obi na-efe efe (ulcerative colitis). Nnyocha e mere na mbụ gosiri na ịgbakwunye Saccharomyces boulardii na usoro ọgwụgwọ mesalamine nwere ike belata mgbaàmà nke ndị nwere obere ọnya afọ.
  • Canker ọnya.
  • Ahụ ikpo ọkụ.
  • Na-amị.
  • Lactose ekweghị ibe nọrọ.
  • Ọrịa Lyme.
  • Mgbu akwara kpatara mmega ahụ.
  • Urinary tract ọrịa (UTIs).
  • Yist ọrịa.
  • Ọnọdụ ndị ọzọ.
A choro ihe akaebe karia iji choo Saccharomyces boulardii maka ojiji ndi a.

A na-akpọ Saccharomyces boulardii "probiotic," ihe na-eme enyi nke na-enyere aka ịlụ ọgụ megide nje na-akpata ọrịa na eriri afọ dịka nje na yist.

Mgbe e were ya n'ọnụ: Saccharomyces boulardii bu O yikarịrị ka ọ dị nchebe maka ọtụtụ ndị okenye mgbe ejiri ọnụ n'ọnụ ha ruo ọnwa iri na ise. Ọ nwere ike ibute gas n’ụfọdụ mmadụ. Obere oge, ọ nwere ike ibute ọrịa fungal nke nwere ike gbasaa site n'ọbara rue ahụ dum (fungemia).

Akpachapụ anya na ịdọ aka na ntị:

Ime ime na ara-ara: Enweghị ozi zuru ezu a pụrụ ịdabere na ya iji mara ma Saccharomyces boulardii dị mma iji mee ihe mgbe ọ dị ime ma ọ bụ na-enye nwa ara. Nọrọ na mma n'akụkụ ma zere ojiji.

Mụaka: Saccharomyces boulardii bu Enwere ike nchekwa maka ụmụaka mgbe e were n'ọnụ ya n'ụzọ kwesịrị ekwesị. Agbanyeghị, onye ọrụ ahụike ga-enyocha afọ ọsịsa na ụmụaka tupu iji Saccharomyces boulardii.

Agadi: Ndị agadi nwere ike ịnwe nnukwu nsogbu nke fungal mgbe ha na-ewere Saccharomyces boulardii. Nọrọ na mma n'akụkụ ma zere ojiji.

Adịghị ike usoro: Enwere ụfọdụ nchegbu na ibute Saccharomyces boulardii nwere ike ibute fungemia, nke bụ ọnụnọ yist na ọbara. Onu ogugu nke Saccharomyces boulardii metụtara fungemia siri ike ikpebi. Otú ọ dị, ihe ize ndụ ahụ yiri ka ọ kasị njọ nye ndị na-arịa ọrịa ma ọ bụ ndị na-adịghị ike usoro nchebe. Karịsịa, ndị nwere catheter, ndị na-enweta nri nri tub, na ndị a na-agwọ ọtụtụ ọgwụ nje ma ọ bụ ọgwụ nje na-arụ ọrụ n'ọtụtụ ọrịa dị iche iche yiri ka ọ kacha nwee ihe egwu. N'ọtụtụ ọnọdụ, fungemia na-esite na ikuku, ikuku gburugburu, ma ọ bụ aka emetọ na Saccharomyces boulardii.

Yist nke nfụkasị: Ndị mmadụ na ọrịa yist nwere ike ịbụ nfụkasị na ngwaahịa nwere Saccharomyces boulardii, ma bụrụ ndị a dụrụ ọdụ ka ha zere ngwaahịa ndị a.

Obere
Lezie anya na nchikota a.
Ọgwụ maka ọrịa fungal (Antifungals)
Saccharomyces boulardii bụ ero. Ọgwụ maka ọrịa fungal na-enyere aka belata ero na ahụ. Iwere Saccharomyces boulardii nwere ogwu maka oria fungal nwere ike belata nchacha nke Saccharomyces boulardii.
Medicationsfọdụ ọgwụ maka ọrịa fungal gụnyere fluconazole (Diflucan), caspofungin (Cancidas), itraconazole (Sporanox) amphotericin (Ambisome), na ndị ọzọ.
Enweghi mmekorita ya na ahihia na mmeju.
Enweghi mmekorita ya na ihe oriri.
A na-amụ usoro ndị a na nyocha sayensị:

NDUL okenye

N'okwu:
  • Maka afọ ọsịsa nke ndị mmadụ na-a antibioticsụ ọgwụ nje (afọ ọsịsa jikọtara ọgwụ mgbochi): A na-ejikarị 250-500 mg nke Saccharomyces boulardii ewere 2-4 ugboro kwa ụbọchị ruo izu 2. N'ọtụtụ ọnọdụ, usoro ọgwụgwọ kwa ụbọchị anaghị agafe 1000 mg kwa ụbọchị.
  • Maka ibute ọrịa nke eriri afọ site na nje bacteria a na-akpọ Clostridium nira: Iji gbochie nlọghachi azụ, 500 mg nke Saccharomyces boulardii ugboro abụọ kwa ụbọchị maka izu 4 yana ọgwụgwọ ọgwụ nje ejirila.
  • Maka ọrịa na-agbari nri nke nwere ike ibute ọnya (Helicobacter pylori ma ọ bụ H. pylori): 500-1000 mg nke Saccharomyces boulardii kwa ụbọchị maka izu 1-4 na-ejikarị eme ihe.
  • Maka afọ ọsịsa nke ndị nwere HIV / AIDS: Gram atọ nke Saccharomyces boulardii kwa ubochi.
  • Maka afọ ọsịsa nke ndị njem: 250-1000 mg nke Saccharomyces boulardii kwa ubochi maka onwa 1.
M .AKA

N'okwu:
  • Maka afọ ọsịsa nke ndị mmadụ na-a antibioticsụ ọgwụ nje (afọ ọsịsa jikọtara ọgwụ mgbochi): A na-eji 250 mg nke Saccharomyces boulardii otu ugboro ma ọ bụ ugboro abụọ kwa ụbọchị maka oge ọgwụ nje.
  • Maka afọ ọsịsa: Maka ịgwọ oke afọ ọsịsa, ejiri 250 mg nke Saccharomyces boulardii otu ugboro ma ọ bụ ugboro abụọ kwa ụbọchị ma ọ bụ 10 ijeri ngalaba na-akpụ otu ugboro kwa ụbọchị maka ụbọchị 5. Maka ịgwọ afọ ọsịsa na-adịgide adịgide, a na-eji ijeri 1750 na 175 na-arụpụta ngalaba nke Saccharomyces boulardii ugboro abụọ kwa ụbọchị maka ụbọchị 5. Maka igbochi afọ ọsịsa na ndị mmadụ na-enweta nri nri tub, eji 500 mg nke Saccharomyces boulardii ugboro anọ kwa ụbọchị.
  • Maka afọ ọsịsa nke rotavirus kpatara: 200-250 mg nke Saccharomyces boulardii ugboro abụọ kwa ụbọchị maka ụbọchị 5 ejirila.
  • Maka ajọ ọrịa eriri afọ na ụmụ aka akaghi aka (necrotizing enterocolitis ma ọ bụ NEC): 100-200 mg / kg Saccharomyces boulardii kwa ubochi, bido n’izu mbu mgbe amuchara nwa.
Probiotic, Probiotique, Saccharomyces Boulardii CNCM I-745, Saccharomyces Boulardii HANSEN CBS 5926, Saccharomyces Boulardii Lyo CNCM I-745, Saccharomyces Boulardius, Saccharomyces Cerevisiae Boulardiius, Saccharomyces Cresvis, Cerevisiae HANSEN CBS 5926, Saccharomyces cerevisiae var boulardii, S. Boulardii, SCB.

Iji mụtakwuo banyere otú e si dee isiokwu a, biko lee Natural Medicines Comprehensive database usoro.


  1. Florez ID, Veroniki AA, Al Khalifah R, et al. Mmetụta dị mma na nchekwa nke mmechi maka nnukwu afọ ọsịsa na ọrịa na-efe efe na ụmụaka: Nyocha nyocha na ntanetị meta. Ejiri otu. Ọgwụ. 2018; 13: e0207701. Lelee anya.
  2. Harnett JE, Pyne DB, McKune AJ, Penm J, Pumpa KL. Nkọwapụta Mgbakwunye probiotic na-eweta mgbanwe dị mma na mgbu ahụ na ogo ụra na ndị egwuregwu rugby. J Sci Ahụike egwuregwu. 2020: S1440-244030737-4. Lelee anya.
  3. Gao X, Wang Y, Shi L, Feng W, Yi K. Mmetụta na nchekwa nke Saccharomyces boulardii maka necrotizing necorotizing enterocolitis na ụmụ ọhụrụ tupu oge eruo: Nyocha nyocha na meta-analysis. J Trop Pediatr. 2020: fmaa022. Lelee anya.
  4. Mourey F, Sureja V, Kheni D, et al. Otu ọnụọgụ dị iche iche, nke a na-ahụkarị, nke nwere ụzọ abụọ, nke a na-achịkwa ebe a na-achịkwa nke Saccharomyces boulardii na ụmụ ọhụrụ na ụmụaka nwere nnukwu afọ ọsịsa. Ọrịa Pediatr Ọrịa J. 2020; 39: e347-e351. Lelee anya.
  5. Karbownik MS, Kr & eogon; czy & nacute; ska J, Kwarta P, et al. Mmetụta nke mgbakwunye na Saccharomyces boulardii na arụmọrụ nyocha agụmakwụkwọ na nrụgide metụtara ya na ụmụ akwụkwọ ahụike ahụike: Ọdịdị a na-ahụkarị, ihu abụọ, nyocha ebebo. Nri. 2020; 12: 1469. Lelee anya.
  6. Zhou BG, Chen LX, Li B, Wan LY, Ai YW. Saccharomyces boulardii dị ka ọgwụgwọ adjuvant maka mkpochapu Helicobacter pylori: Nyocha nyocha na usoro nyocha na usoro nyocha usoro. Helicobacter. Ọrịa. 2019; 24: e12651. Lelee anya.
  7. Szajewska H, ​​Kolodziej M, Zalewski BM. Nyocha usoro na meta-analysis: Saccharomyces boulardii maka ịgwọ nnukwu gastroenteritis na ụmụaka-mmelite 2020. Aliment Pharmacol Ther. 2020. Elele anya.
  8. Seddik H, Boutallaka H, ​​Elkoti I, et al. Saccharomyces boulardii CNCM I-745 gbakwunyere usoro ọgwụgwọ usoro maka ọrịa Helicobacter pylori: usoro enweghị usoro, imeghe. Eur J Clin Pharmacol. Ọrịa. 2019; 75: 639-645. Lelee anya.
  9. García-Collinot G, Madrigal-Santillán EO, Martínez-Bencomo MA, et al. Mmetụta nke Saccharomyces boulardii na Metronidazole maka obere eriri afọ nke nje na-akpata na systemic sclerosis. 2019. Elele anya.
  10. McDonald LC, Gerding DN, Johnson S, et al.; Ọrịa Na-efe Ọrịa nke America. Usoro nlekọta ahụike maka ọrịa Clostridium siri ike na ndị okenye na ụmụaka: mmelite 2017 site na Infectious Diseases Society of America (IDSA) na Society of Healthcare Epidemiology of America (SHEA). Ọrịa Ọrịa Na-efe Ọrịa 2018; 66: e1-e48.
  11. Xu L, Wang Y, Wang Y, et al. Na Na Na Na Na Na Na Na Na Na Na Na et et al. Ọnwụnwa okpukpu abụọ kpuru ìsì na-eto eto ma na-eri nri na Saccharomyces boulardii CNCM I-745 na ụmụ ọhụrụ na-enye nri ụmụaka. J Pediatr (Rio J). 2016; 92: 296-301. Lelee anya.
  12. Sheele J, Cartowski J, Dart A, et al. Saccharomyces boulardii na bismuth subsalicylate dika ntinye aka di ala iji belata oge na oke nke cholera. Pathog Global Health. 2015; 109: 275-82. Lelee anya.
  13. Ryan JJ, Hanes DA, Schafer MB, Mikolai J, Zwickey H. Mmetụta nke Probiotic Saccharomyces boulardii na Cholesterol na Lipoprotein Ngwakọta na Ndị Okenye Hypercholesterolemic: Otu Ogwe Aka, Imeghe-Label Pilot. J Ọzọ Mgbakwunye Med. 2015; 21: 288-93. Lelee anya.
  14. Flatley EA, Wilde AM, Nailor MD. Saccharomyces boulardii maka mgbochi nke ụlọ ọgwụ na mbido Clostridium nsogbu ọrịa. J Gastrointestin Ọrịa Dis. 2015; 24: 21-4. Lelee anya.
  15. Ehrhardt S, Guo N, Hinz R, et al. Saccharomyces boulardii iji gbochie ọrịa ogbu na nkwonkwo na-akpata ọrịa: A Randomized, Double-Masked, Placebo-Controlled Trial. Imepe Ọrịa Na-ahụ Maka Ọrịa. 2016; 3: nke of011. Lelee anya.
  16. Dinleyici EC, Kara A, Dalgic N, et al. Saccharomyces boulardii CNCM I-745 na-ebelata oge afọ ọsịsa, ogologo oge nlekọta mberede na ịnọ n'ụlọ ọgwụ na ụmụaka nwere nnukwu afọ ọsịsa. Uru Microbes. Ọrịa. 2015; 6: 415-21. Lelee anya.
  17. Dauby N. Risks of Saccharomyces boulardii-Nwere Probiotics maka Mgbochi nke Ọrịa Clostridium siri ike na Agadi. Ọrịa. Ọrịa. 2017; 153: 1450-1451. Lelee anya.
  18. Cottrell J, Koenig K, Perfekt R, Hofmann R; Loperamide-Simethicone Nnukwu Otu Na-amụ Ihe Ọsịsa. N'iji tụnyere Twodị Abụọ nke Loperamide-Simethicone na Yist Probiotic (Saccharomyces boulardii) na Ọgwụ nke Ọrịa Nnukwu Ọrịa na Ndị okenye: Achọpụta Ahụhụ Na-adịghị Nsogbu Na-enweghị Ọrịa. Ọgwụ R D. 2015; 15: 363-73. Lelee anya.
  19. Costanza AC, Moscavitch SD, Faria Neto HC, Mesquita ET. Usoro ọgwụgwọ ọgwụ na Saccharomyces boulardii maka ndị na-arịa ọrịa obi: a na-ahụkarị, ihu abụọ, nyocha ebe a na-achịkwa ebebo. Int J Cardiol. 2015; 179: 348-50. Lelee anya.
  20. Carstensen JW, Chehri M, Schønning K, et al. Naịjirịa Ojiji nke prophylactic Saccharomyces boulardii iji gbochie oria Clostridium siri ike na ndị ọrịa nọ n'ụlọ ọgwụ: a na-achịkwa ịmụ anya ọmụmụ ihe. Eur J Clin Microbiol Inye Ọrịa. Ọgwụ. 2018; 37: 1431-1439. Lelee anya.
  21. Asmat S, Shaukat F, Asmat R, Bakhat HFSG, Asmat TM. Njikọ Ọrịa Nlekọta Ahụike nke Saccharomyces Boulardii na Lactic Acid dị ka Probiotics na Nnukwu Ọrịa edimụaka Ọrịa. Ndị dọkịta J Coll Surg Pak. Ọgwụ. 2018; 28: 214-217. Lelee anya.
  22. Remenova T, Morand O, Amato D, Chadha-Boreham H, Tsurutani S, Marquardt T. Otu onye kpuru ìsì abụọ, nke a na-achịkwa, nke a na-achịkwa ebe a na-achịkwa ebebo na-amụ mmetụta nke Saccharomyces boulardii na ndidi, nchekwa, na pharmacokinetics nke miglustat. Nwa akwukwo Oriri J Rare Dis 2015; 10: 81. Lelee anya.
  23. Suganthi V, Das AG. Ọrụ nke Saccharomyces boulardii na mbelata hyperbilirubinemia nke neonatal. J Ọrịa Diagn Res 2016; 10: SC12-SC15. Lelee anya.
  24. Riaz M, Alam S, Malik A, Ali SM. Fficrụ ọrụ na nchekwa nke Saccharomyces boulardii na nnukwu afọ ọsịsa nke nwata: ọnụọgụ abụọ kpuru ìsì na-achịkwa ikpe. Ndị India J Pediatr 2012; 79: 478-82. Lelee anya.
  25. - Corrêa NB, Penna FJ, Lima FM, Nicoli JR, Filho LA. Ọgwụgwọ oke afọ ọsịsa na Saccharomyces boulardii na umu aka. J Pediatr Gastroenterol Nutr 2011; 53: 497-501. Lelee anya.
  26. Cohen SH, Gerding DN, Johnson S, et al.; Society maka Ahụike Epidemiology nke America; Ọrịa Na-efe Ọrịa nke America. Clinical omume ụkpụrụ nduzi maka Clostridium siri ọrịa na ndị okenye: 2010 update site na otu maka ahụike epidemiology nke America (SHEA) na ọrịa na-efe ọha mmadụ nke America (IDSA). Hosplọ Ọrịa Na-ahụ Maka Ọrịa 2010; 31: 431-55. Lelee anya.
  27. Goldenberg JZ, Ma SS, Saxton JD, et al. Mgbakwunye Probiotics maka igbochi Clostridium siri ike metụtara afọ ọsịsa na ndị okenye na ụmụaka. Cochrane Database Syst Rev. 2013;: CD006095. Lelee anya.
  28. Lau CS, Chamberlain RS. Probiotics dị irè na igbochi afọ ọsịsa metụtara Clostridium siri ike: nyocha nhazi na meta-analysis. Int J Gen Ahụike. Ọrịa. 2016; 9: 27-37. Lelee anya.
  29. Roy U, Jessani LG, Rudramurthy SM, et al. Usoro asaa nke Saccharomyces fungaemia metụtara iji probiotics. Mycoses 2017; 60: 375-380. Lelee anya.
  30. Romanio MR, Coraine LA, Maielo VP, Abramczyc ML, Souza RL, Oliveira NF. Saccharomyces cerevisiae fungemia na onye na-arịa ọrịa pediatric mgbe a gwọchara ya na probiotics. Mkpu Paul Pediatr 2017; 35: 361-4. Lelee anya.
  31. Pozzoni P, Riva A, Bellatorre AG, et al. Saccharomyces boulardii maka mgbochi nke afọ ọsịsa jikọtara ọgwụ nje na ndị okenye nọ n'ụlọ ọgwụ: otu etiti, esemokwu, abụọ isi, nyocha ikpe ebebo. Am J Gastroenterol 2012; 107: 922-31. Lelee anya.
  32. Martin IW, Tonner R, Trivedi J, et al. Azụmahịa Saccharomyces boulardii probiotic-metụtara fungemia: ịjụ nchekwa nke usoro mgbochi probiotic a. Diagn Microbiol Inye Ahụike Dis. Ọrịa. 2017; 87: 286-8. Lelee anya.
  33. Choi CH, Jo SY, Ogige HJ, Chang SK, Byeon JS, Myung SJ. Ihe a na-ahụ anya, nke kpuru ìsì abụọ, nke a na-achịkwa ebebo nke Saccharomyces boulardii na ọrịa obi bowel na-ewe iwe: mmetụta na ndụ nke ndụ. J Ọrịa Gastroenterol. 2011; 45: 679-83. Lelee anya.
  34. Atici S, Soysal A, Karadeniz Cerit K, et al. Catchater metụtara Saccharomyces cerevisiae Fungemia Followinggbaso Saccharomyces boulardii Probiotic Treatment: N'ime nwatakiri na ngalaba nlekọta kpụ ọkụ n'ọnụ na nyochaa akwụkwọ. Ahụike Mycol Case Rep. 2017; 15: 33-35. Lelee anya.
  35. Appel-da-Silva MC, Narvaez GA, Perez LRR, Drehmer L, Lewgoy J. Saccharomyces cerevisiae var. boulardii fungemia na-eso ọgwụgwọ probiotic. Ahụike Mycol Case Rep. 2017; 18: 15-7. Lelee anya.
  36. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Otutu nsogbu probiotics pụtara ịbụ probiotics kachasị dị irè na mgbochi nke necrotizing enterocolitis na ịnwụ: Ihe emelitere meta-analysis. Ejiri otu. Ọrịa. 2017; 12: e0171579. Lelee anya.
  37. Blaabjerg S, Artzi DM, Aabenhus R. Probiotics for the Prevention of Antibiotic-Associated Dilera na ndị ọrịa na-apụ apụ-Nyocha usoro na Meta-Analysis. Ọgwụ nje (Basel). Ọrịa. 2017; 6. Lelee anya.
  38. Al Faleh K, Anabrees J. Probiotics maka igbochi necrotizing enterocolitis na ụmụ ọhụrụ. Cochrane Database Syst Rev. 2014;: CD005496. Lelee anya.
  39. Das S, Gupta PK, Das RR. Nrụpụta ọrụ na nchekwa nke Saccharomyces boulardii na Nnukwu afọ ọsịsa nke Rotavirus: Ọnwụnwa a na-achịkwa nke abụọ amachara site na mba na-emepe emepe. J Trop Pediatr. 2016; 62: 464-470. Lelee anya.
  40. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Probiotics maka igbochi pediatric ọgwụ nje metụtara afọ ọsịsa. Cochrane Database Syst Rev. 2015;: CD004827. Lelee anya.
  41. Feizizadeh S, Salehi-Abargouei A, Akbari V. Nrụpụta ọrụ na nchekwa nke Saccharomyces boulardii maka nnukwu afọ ọsịsa. Ọrịa ụmụaka. 2014; 134: e176-191. Lelee anya.
  42. Szajewska H, ​​Horvath A, Kolodziej M. Nyocha nyocha na usoro nyocha: Saccharomyces boulardii supplementation na mkpochapu ọrịa Helicobacter pylori. Aliment Pharmacol Ther. 2015; 41: 1237-1245. Lelee anya.
  43. Szajewska H, ​​Kolodziej M. Nyocha nyocha na nyocha-meta: Saccharomyces boulardii na mgbochi nke ọgwụ nje -ajikọtara afọ ọsịsa. Aliment Pharmacol Ther. 2015; 42: 793-801. Lelee anya.
  44. Ellouze O, Berthoud V, Mervant M, Parthiot JP, Girard C. Septic ujo n'ihi Sacccaromyces boulardii. Ahụike Mal Mal. 2016; 46: 104-105. Lelee anya.
  45. Bafutto M, et al. Ọgwụgwọ afọ ọsịsa-nke nwere nnukwu ọnya afọ na mesalamine na / ma ọ bụ Saccharomyces boulardii. Uche Ogbuagu Ọrịa. 2013; 50: 304-309. Lelee anya.
  46. Bourreille A, et al. Saccharomyces boulardii anaghị egbochi nlọghachi nke ọrịa Crohn. Ọrịa Gastroenterol Hepatol. Ọrịa. 2013; 11: 982-987.
  47. Serce O, Gursoy T, Ovali F, Karatekin G. Mmetụta nke Saccaromyces boulardii na neonatal hyperbilirubinemia: usoro nchịkwa a na-achịkwa. Am J Perinatol. Ọrịa. 2015; 30: 137-142. Lelee anya.
  48. Videlock EJ, Cremonini F. Meta-analysis: probiotics na ọgwụ nje metụtara ọrịa afọ ọsịsa. Aliment Pharmacol Ther. 2012; 35: 1355-69. Lelee anya.
  49. Hempel S, Newberry SJ, Maher AR, Wang Z, Miles JN, Shanman R, Johnsen B, Shekelle PG. Probiotics maka igbochi na ọgwụgwọ nke ogwu na-emetụta afọ ọsịsa: nyocha nhazi na meta-analysis. JAMA. 2012 9; 307: 1959-69. Lelee anya.
  50. Elmer GW, Moyer KA, Vega R, na et al. Nyocha nke Saccharomyces boulardii maka ndị ọrịa nwere ọrịa afọ ọsịsa na-arịa ọrịa HIV na ndị ọrụ afọ ofufo ahụike na-anata antifungals. Microecology Nta 1995; 25: 23-31.
  51. Potts L, Lewis SJ, na Barry R. Randomized abụọ kpuru ìsì placebo achịkwa ọmụmụ nke ikike nke Saccharomyces boulardii iji gbochie ọgwụ nje metụtara afọ ọsịsa [nkịtị]. Gut 1996; 38 (bunye 1): A61.
  52. Bleichner G na Blehaut H. Saccharomyces boulardii na-egbochi afọ ọsịsa na ndị ọrịa na-arịa ọrịa tube. Onye na-achịkwa ọtụtụ ebe, nke a na-ahụkarị, nke nwere ihu abụọ a na-achịkwa ebebo. Nleta Nutr 1994; 13 Suppl 1:10.
  53. Maupas JL, Champemont P, na Delforge M. [Ọgwụgwọ ọrịa obi na-ewe iwe na Saccharomyces boulardii - okpukpu abụọ, nyocha ebe a na-achịkwa ebebo]. Médicine et Chirurgie Digestives 1983; 12: 77-79.
  54. Saint-Marc T, Blehaut H, Musial C, na et al. [Afọ ọsịsa metụtara ọrịa AIDS: nnwale ihu abụọ nke Saccharomyces boulardii]. Semaine Des Hopitaux 1995; 71 (23-24): 735-741.
  55. McFarland LV, Surawicz C, Greenberg R, na et al. Saccharomyces boulardii na akwa dose vancomycin na-agwọ ugboro ugboro Clostridium nsogbu ọrịa [nkịtị]. Am J Gastroenterol 1998; 93: 1694.
  56. Chouraqui JP, Dietsch J, Musial C, na et al. Saccharomyces boulardii (SB) na njikwa nke afọ ọsịsa nke afọ nwata: ọmụmụ a na-achịkwa ụzọ abụọ nwere isi [adịghị adị]. J Pediatr Gastroenterol Nutr 1995; 20: 463.
  57. Cetina-Sauri G na Basto GS. Evaluacion terapeutica de Saccharomyces boulardii en ninos con diarrea aguda. Tribuna Med 1989; 56: 111-115.
  58. Adam J, Barret C, Barret-Bellet A, yana et al. Essais cliniques controles en okpukpu abụọ insu de l'Ultra-Levure Lyophilisee. Etude multicentrique par 25 medecins de 388 cas. Gaz Med Fr 1977; 84: 2072-2078.
  59. McFarland LV, SurawiczCM, Elmer GW, na et al. Nyocha dị iche iche nke nrụpụta ahụike nke ọgwụ na-arụ ọrụ biotherapeutic, Saccharomyces boulardii maka mgbochi ọrịa afọ ọsịsa metụtara mkpụrụ ọgwụ [nkịtị]. Am J Epidemiol 1993; 138: 649.
  60. Saint-Marc T, Rossello-Prats L, na Touraine JL. [Irè nke Saccharomyces boulardii na njikwa nke afọ ọsịsa nke ọrịa AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65.
  61. Kirchhelle, A., Fruhwein, N., na Toburen, D. [Ọgwụgwọ afọ ọsịsa na-adịgide adịgide na S. boulardii na ndị njem na-alọta. Nsonaazụ nke ọmụmụ a gaje ịmụ]. Akwụkwọ Ọrịa 4-20-1996; 114: 136-140. Lelee anya.
  62. Amụrụ, P., Lersch, C., Zimmerhackl, B., na Classen, M. [Usoro ọgwụgwọ ọrịa saccharomyces nke afọ ọsịsa metụtara HIV]. Dtsch Med Wochenschr 5-21-1993; 118: 765. Lelee anya.
  63. Kollaritsch, H., Holst, H., Grobara, P., na Wiedermann, G. [Na-egbochi afọ ọsịsa nke ndị njem na Saccharomyces boulardii. Nsonaazụ nke otu placebo na-achịkwa ọmụmụ ihu abụọ. Ndabere na Fortschr.Med 3-30-1993; 111: 152-156. Lelee anya.
  64. Tempe, J. D., Steidel, A. L., Blehaut, H., Hasselmann, M., Lutun, P., na Maurier, F. [Mgbochi afọ ọsịsa nke na-enye Saccharomyces boulardii n'oge nri na-aga n'ihu]. Nkechi 5-5-1983; 59: 1409-1412. Lelee anya.
  65. Chapoy, P. [Ọgwụgwọ nnukwu afọ ọsịsa nke ụmụ ọhụrụ: ikpe a na-achịkwa nke Saccharomyces boulardii]. Ann Pediatr. (Paris) 1985; 32: 561-563. Lelee anya.
  66. Kimmey, M. B., Elmer, G. W., Surawicz, C. M., na McFarland, L. V. Mgbochi nke nlọghachi ọzọ nke Clostridium nsogbu colitis na Saccharomyces boulardii. Dig.Dis Sci 1990; 35: 897-901. Lelee anya.
  67. Saint-Marc, T., Rossello-Prats, L., na Touraine, J. L. [Mmetụta nke Saccharomyces boulardii na ọgwụgwọ nke afọ ọsịsa na ọrịa AIDS]. Ann Med Interne (Paris) 1991; 142: 64-65. Lelee anya.
  68. Duman, DG, Bor, S., Ozutemiz, O., Sahin, T., Oguz, D., Istanbul, F., Vural, T., Sandkci, M., Isksal, F., Simsek, I., Soyturk , M., Arslan, S., Sivri, B., Soykan, I., Temizkan, A., Bessk, F., Kaymakoglu, S., na Kalayc, C. nrụpụta ọrụ na nchekwa nke Saccharomyces boulardii na mgbochi nke ọgwụ nje- metụtara afọ ọsịsa n'ihi mkpochapu Helicobacterpylori. Eur J Gastroenterol. Hepatol. 2005; 17: 1357-1361. Lelee anya.
  69. Surawicz, C. M. Ọgwụgwọ nke ọrịa metụtara Clostridium na-agbagha. Nat Clin Pract.Gastroenterol.Hepatol. 2004; 1: 32-38. Lelee anya.
  70. Kurugol, Z. na Koturoglu, G. Mmetụta nke Saccharomyces boulardii n’ime ụmụaka nwere nnukwu afọ ọsịsa. Ọrụ Paediatr. Ọrịa. 2005; 94: 44-47. Lelee anya.
  71. Kotowska, M., Albrecht, P., na Szajewska, H. Saccharomyces boulardii na mgbochi nke afọ ọsịsa na-emetụta ụmụaka: usoro ikpebi ebe a na-achịkwa ụzọ abụọ. Aliment. Pharmacol. Nke-ọzọ. 3-1-2005; 21: 583-590. Lelee anya.
  72. Cherifi, S., Robberecht, J., na Miendje, Y. Saccharomyces cerevisiae fungemia na onye agadi meworo ọrịa Clostridium nsogbu colitis. Ihe omume Clin Belg. 2004; 59: 223-224. Lelee anya.
  73. Erdeve, O., Tiras, U., na Dallar, Y. Mmetụta probiotic nke Saccharomyces boulardii na otu ọgbọ ụmụaka. J Trop. Pediatr. Ọrịa. 2004; 50: 234-236. Lelee anya.
  74. Costalos, C., Skouteri, V., Gounaris, A., Sevastiadou, S., Triandafilidou, A., Ekonomidou, C., Kontaxaki, F., na Petrochilou, V. Inye aka na nri ụmụ aka akaghi aka na Saccharomyces boulardii. Mmalite Hum.Dev. Ọrịa. 2003; 74: 89-96. Lelee anya.
  75. Gaon, D., Garcia, H., Winter, L., Rodriguez, N., Quintas, R., Gonzalez, S. N., na Oliver, G. Mmetụta nke nsogbu Lactobacillus na Saccharomyces boulardii na-arịa afọ ọsịsa na ụmụaka. Medicina (B Aires nke dị na 2003); 63: 293-298. Lelee anya.
  76. Mansour-Ghanaei, F., Dehbashi, N., Yazdanparast, K., na Shafaghi, A. Mmetụta nke saccharomyces boulardii nwere ọgwụ nje na nnukwu amoebiasis. Jwa J Gastroenterol. Ọrịa. 2003; 9: 1832-1833. Lelee anya.
  77. Riquelme, A.J., Calvo, M. A., Guzman, A.M., Depix, M. S., Garcia, P., Perez, C., Arrese, M., na Labarca, J. A. Saccharomyces cerevisiae fungemia mgbe ọgwụgwọ Saccharomyces boulardii na ndị ọrịa na-egbochi ọrịa. Clinlọọgwụ Gastroenterol. Ọrịa. 2003; 36: 41-43. Lelee anya.
  78. Cremonini, F., Di Caro, S., Santarelli, L., Gabrielli, M., Candelli, M., Nista, EC, Lupascu, A., Gasbarrini, G., na Gasbarrini, A. Probiotics na ọgwụ nje metụtara afọ ọsịsa. Ugwu Digiri. 2002; 34 Na-enye 2: S78-S80. Lelee anya.
  79. Lherm, T., Monet, C., Nougiere, B., Soulier, M., Larbi, D., Le Gall, C., Caen, D., na Malbrunot, C. Okwu asaa nke fungemia na Saccharomyces boulardii na nkatọ ndị ọrịa. Nlekọta Na-ahụ Maka Ahụ Ike 2002; 28: 797-801. Lelee anya.
  80. Tasteyre, A., Barc, M. C., Karjalainen, T., Bourlioux, P., na Collignon, A. Mgbochi nke in vitro cell nrapara nke Clostridium siri ike site na Saccharomyces boulardii. Microb.Pathog. Ọrịa. 2002; 32: 219-225. Lelee anya.
  81. Shanahan, F. Nje ọgwụ na ọnya afọ. Olu 2001; 48: 609. Lelee anya.
  82. Surawicz, CM, McFarland, LV, Greenberg, RN, Rubin, M., Fekety, R., Mulligan, ME, Garcia, RJ, Brandmarker, S., Bowen, K., Borjal, D., na Elmer, GW The chọọ ọgwụgwọ ka mma maka ọrịa Clostridium siri ike na-abịaghachi: iji ọgwụ vancomycin dị elu tinyere Saccharomyces boulardii. Ọrịa. Ọrịa. 2000; 31: 1012-1017. Lelee anya.
  83. Johnston BC, Ma SSY, Goldenberg JZ, et al. Nke a Probiotics maka igbochi ọrịa afọ ọsịsa na-emetụta Clostridium. Ann Intern Med 2012; 157: 878-8. Lelee anya.
  84. Munoz P, Bouza E, Cuenca-Estrella M, et al. Achọpụta ndị ọzọ Saccharomyces cerevisiae fungemia: ọrịa na-efe efe. Ọrịa Na-ahụ Maka Ọrịa 2005; 40: 1625-34. Lelee anya.
  85. Szajewska H, ​​Mrukowicz J. Meta-analysis: yist na-enweghị pathogenic Saccharomyces boulardii na mgbochi nke afọ ọsịsa metụtara afọ ọsịsa. Aliment Pharmacol Ther 2005; 22: 365-72. Lelee anya.
  86. Nwere ike M, Besirbellioglu BA, Avci IY, et al. Prophylactic Saccharomyces boulardii na mgbochi nke ọrịa afọ ọsịsa metụtara: A na-achọ ịmụ ihe. Med Sci Monit 2006; 12: PI19-22. Lelee anya.
  87. Guslandi M, Giollo P, Testoni PA. Ọnwụnwa ọnwụnwa nke Saccharomyces boulardii na ọnya afọ. Eur J Gastroenterol Hepatol 2003; 15: 697-8. Lelee anya.
  88. Guslandi M, Mezzi G, Sorghi M, Testoni PA. Saccharomyces boulardii na nlekota oru nke oria Crohn. Gwa Digi Sci 2000; 45: 1462-4. Lelee anya.
  89. McFarland LV. Meta-nyocha nke probiotics maka igbochi ọgwụ nje metụtara afọ ọsịsa na ọgwụgwọ ọrịa Clostridium siri ike. Am J Gastroenterol 2006; 101: 812-22. Lelee anya.
  90. Marteau P, Seksik P. Ndidi nke probiotics na prebiotics. J Ọrịa Gastroenterol 2004; 38: S67-9. Lelee anya.
  91. Borriello SP, Hammes WP, Holzapfel W, et al. Nchedo probiotics nke nwere lactobacilli ma ọ bụ bifidobacteria. Ọrịa Ọrịa 2003; 36: 775-80. Lelee anya.
  92. Cremonini F, Di Caro S, Covino M, et al. Achọpụta nke ọma Mmetụta nke nkwadebe ọgwụ probiotic dị iche iche na ọgwụ mgbochi-emetụta helibabacter pylori metụtara: otu ihe yiri ya, okpukpu atọ, ọmụmụ a na-achịkwa ebebo. Am J Gastroenterol 2002; 97: 2744-9. Lelee anya.
  93. D'Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics na mgbochi nke ọgwụ nje metụtara afọ ọsịsa: meta-analysis. BMJ 2002; 324: 1361. Lelee anya.
  94. Muller J, Remus N, Harms KH. Mycoserological ọmụmụ nke ọgwụgwọ pediatric cystic fibrosis ọrịa na Saccharomyces boulardii (Saccharomyces cerevisiae Hansen CBS 5926). Mycoses 1995; 38: 119-23. Lelee anya.
  95. Plein K, Hotz J. Mmetụta ọgwụgwọ nke Saccharomyces boulardii na obere ihe mgbaàmà fọdụrụnụ na mpaghara nke anụ Crohn nwere nkwanye ùgwù pụrụ iche maka afọ ọsịsa na-adịghị ala ala - nchọpụta pilot. Z Gastroenterol 1993; 31: 129-34. Lelee anya.
  96. Hennequin C, Thierry A, Richard GF, et al. Microsatellite na-ede ihe dị ka ngwa ọrụ ọhụụ maka ịmata ụdị nsogbu Saccharomyces cerevisiae. J Ọrịa Microbiol 2001; 39: 551-9. Lelee anya.
  97. Cesaro S, Chinello P, Rossi L, Zanesco L. Saccharomyces cerevisiae fungemia na onye ọrịa na-egbochi ịgwọ ọrịa nke ejiri Saccharomyces boulardii mesoo. Ọrịa Cancer na-akwado 2000; 8: 504-5. Lelee anya.
  98. Weber G, Adamczyk A, Freytag S. [Ọgwụgwọ nke ihe otutu na nkwadebe yist]. Nhazi obodo 1989; 107: 563-6. Lelee anya.
  99. Lewis SJ, Freedman AR. Nyochaa edemede: ojiji nke ndị na-ahụ maka ihe na-akpata ọrịa na igbochi na ọgwụgwọ ọrịa ọrịa eriri afọ. Imentlọ ọgwụ Aliment Ther 1998; 12: 807-22. Lelee anya.
  100. Krammer M, Karbach U. Antidiarrheal edinam nke yist Saccharomyces boulardii na oke obere na nnukwu eriri afọ site na-akpali akpali chloride absorption. Z Gastroenterol 1993; 31: 73-7.
  101. Czerucka D, Roux I, Rampal P. Saccharomyces boulardii na-egbochi adenosine 3 ’, 5’-cyclic monophosphate na-arụ ọrụ na nzuzo na mkpụrụ ndụ eriri afọ. Gastroenterol 1994; 106: 65-72. Lelee anya.
  102. Elmer GW, McFarland LV, Surawicz CM, et al. Omume nke Saccharomyces boulardii na ndị ọrịa na-arịa ọrịa Clostridium ugboro ugboro. Aliment Pharmacol Ther 1999; 13: 1663-8. Lelee anya.
  103. Fredenucci I, Chomarat M, Boucaud C, et al. Saccharomyces boulardii fungemia na onye ọrịa na-enweta ọgwụgwọ ọgwụgwọ ole na ole. Ọrịa Na-ahụ Maka Ọrịa 1998; 27: 222-3. Lelee anya.
  104. Pletinex M, Legein J, Vandenplas Y. Fungemia na Saccharomyces boulardii na nwatakịrị nwanyị 1 nwere afọ ọsịsa. J Pediatr Gastroenterol Nutr 1995; 21: 113-5. Lelee anya.
  105. Buts JP, Corthier G, Delmee M. Saccharomyces boulardii maka Clostridium siri ike-metụtara enteropathies na ụmụ ọhụrụ. J Pediatr Gastroenterol Nutr 1993; 16: 419-25. Lelee anya.
  106. Surawicz CM, Elmer GW, Speelman P, et al. Mgbochi ọrịa afọ ọsịsa nke Saccharomyces boulardii metụtara: ọmụmụ a na-achọ. Ọrịa Gastroenterology 1989; 96: 981-8. Lelee anya.
  107. Surawicz CM, McFarland LV, Elmer G, et al. Ọzọ Ọgwụgwọ nke otutu mgbe na-arịa ọrịa mkpokọ anya na vancomycin na Saccharomyces boulardii. Am J Gastroenterol 1989; 84: 1285-7. Lelee anya.
  108. McFarland LV, Surawicz CM, Greenberg RN, et al. Mgbochi ọrịa beta-lactam metụtara afọ ọsịsa nke Saccharomyces boulardii jiri ya tụnyere placebo. Am J Gastroenterol 1995; 90: 439-48. Lelee anya.
  109. McFarland LV, Surawicz CM, Greenberg RN, et al. Ọnwụnwa a na-achịkwa ebe a na-achịkwa nke Saccharomyces boulardii na ọgwụ nje maka ọkọlọtọ maka ọrịa Clostridium. JAMA 1994; 271: 1913-8. Lelee anya.
  110. Elmer GW, McFarland LV. Ikwu banyere enweghi ọgwụgwọ ọgwụgwọ nke Saccharomyces boulardii na mgbochi ọrịa afọ ọsịsa metụtara ọrịa na ndị ọrịa meworo agadi. Ọrịa 1998; 37: 307-8. Lelee anya.
  111. Lewis SJ, Potts LF, Barry RE. Enweghị mmetụta ọgwụgwọ nke Saccharomyces boulardii na igbochi ọrịa afọ ọsịsa nke ọrịa na-arịa ndị agadi. Ọrịa 1998; 36: 171-4. Lelee anya.
  112. Bleichner G, Blehaut H, Mentec H, et al. Mgbakwunye Saccharomyces boulardii na-egbochi afọ ọsịsa na ndị ọrịa na-arịa ọrịa nrịanrịa siri ike. Nlekọta kpụ ọkụ n'ọnụ Med 1997; 23: 517-23. Lelee anya.
  113. Castagliuolo I, Riegler MF, Valenick L, et al. Saccharomyces boulardii protease na-egbochi mmetụta nke toxins A na B nke clostridium siri ike na mucosa mmadụ. Ọrịa na Mgbochi 1999; 67: 302-7. Lelee anya.
  114. Saavedra J. Probiotics na ọrịa afọ ọsịsa na-efe efe. Am J Gastroenterol 2000; 95: S16-8. Lelee anya.
  115. McFarland LV. Saccharomyces boulardii abụghị Saccharomyces cerevisiae. Ọrịa Na-ahụ Maka Ọrịa 1996; 22: 200-1. Lelee anya.
  116. McCullough MJ, Clemons KV, McCusker JH, Stevens DA. Umu anumanu na anumanu nke Saccharomyces boulardii (nom. Inval.). J Ọrịa Microbiol 1998; 36: 2613-7. Lelee anya.
  117. Niault M, Thomas F, Prost J, et al. Nke a Fungemia n'ihi ụdị Saccharomyces na onye ọrịa na-emeso nke Saccharomyces boulardii. Ọrịa Na-ahụ Maka Ọrịa 1999; 28: 930. Lelee anya.
  118. Bassetti S, Frei R, Zimmerli W. Fungemia na Saccharomyces cerevisiae mgbe ọgwụgwọchara Saccharomyces boulardii. Am J Med 1998; 105: 71-2. Lelee anya.
  119. Scarpignato C, Rampal P. Mgbochi na ọgwụgwọ nke afọ ọsịsa nke ndị njem: Usoro ọgwụgwọ ọgwụ. Chemotherapy 1995; 41: 48-81. Lelee anya.
Nyochaa ikpeazụ - 11/10/2020

Na-Enyo Enyo

Lady Gaga kesara ozi dị mkpa gbasara ahụike uche ka ọ na -enye nne ya onyinye
Ndu

Lady Gaga kesara ozi dị mkpa gbasara ahụike uche ka ọ na -enye nne ya onyinye

A nabatara Camila Mende , Madelaine Pet ch, na torm Reid na emume emetụ n'ahụ nke 2018 maka ụmụaka na -edozi obi, ihe anaghị akwụ ụgwọ megide mmegbu na ekweghị ibe nọrọ. Mana Lady Gaga nwere n ọpụ...
Aghụghọ afọ ntachi a na-aga nke ọma na TikTok - mana ọ bụ n'ezie shit?
Ndu

Aghụghọ afọ ntachi a na-aga nke ọma na TikTok - mana ọ bụ n'ezie shit?

Day bọchị ndị a, ọ na-e iri ike ịwụ akpata oyi n'ahụ maka u oro na-emecha na-efe efe na TikTok, ma ọ bụ. na-eme i ike okirikiri gbara ọchịchịrị n'okpuru anya (mgbe ọtụtụ mmadụ nọ ebe a na-agba...